Insurance remains a major source of disparity for patients with testicular cancer: call for advocacy

By sjmartinez • October 27, 2024

Starr S, Zhang J, Lin L, Shen J, Gamalong G, Litwin MS, Drakaki A, Chamie K. Insurance remains a major source of disparity for patients with testicular cancer: call for advocacy. BJU Int. 2024 Oct 25. doi: 10.1111/bju.16568. Epub ahead of print. PMID: 39456120.

Tags: disparities, Hematology/Oncology, insurance status, Medicaid expansion, Publications, Social determinants of health, Testicular cancer

Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm

De Botton S, Récher C, Cortes J, Curti A, Fenaux P, Peterlin P, Pigneux A, Yee K, Wei A, Mims A, Schiller G, Chao MM,[...]

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now

Shore N, Nielsen SM, Esplin ED, Antonarakis ES, Barata PC, Beer TM, Beltran H, Bryce A, Cookson MS, Crawford ED, Dorff TB, George DJ, Heath[...]

Retrospective Study of CD20 Expression Loss in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Marshalek JP, Qing X, Dragan M, Tomassetti S. Retrospective Study of CD20 Expression Loss in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. J Hematol. 2024 Dec;13(6):268-277.[...]